SCM
SIOX

Sio Capital Management’s Sio Gene Therapies Inc. Common Stock SIOX Stock Holding History

Sio Capital Management’s Portfolio SIOX Stock Details SIOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-454,838
Closed -$25M – 71
2017
Q3 		$25M Buy
454,838
+451,125
+12,150% +$76.1M 12.99% 1
2017
Q2 		$689K Buy
+3,713
New +$651K 0.33% 51

Other funds holding SIOX

SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
TVWM
Tower View Wealth Management Shorewood, Wisconsin $227M AUM 41.04% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.61B AUM 28.28% 1-Year Est. Return

Sio Capital Management's SIOX Position: Q2 2021 in Review

Sio Capital Management sold out of Sio Gene Therapies Inc. Common Stock (SIOX) in Q2 2021, closing a stake of 460,248 shares — an estimated $1.2M sold.

Sio Capital Management first reported a position in SIOX in Q3 2017 and held it in 3 quarters. The position peaked at $7.7M in Q3 2017. 54 funds tracked by Wall St. Rank hold SIOX as of Q2 2021.

  • Sio Capital Management reported no remaining Sio Gene Therapies Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Sio Capital Management sold 460,248 Sio Gene Therapies Inc. Common Stock shares in Q2 2021, an estimated $1.2M.
  • Sio Capital Management first reported a position in Sio Gene Therapies Inc. Common Stock in Q3 2017 and held it in 3 quarters.
  • Sio Capital Management's Sio Gene Therapies Inc. Common Stock position peaked at $7.7M in Q3 2017.
  • 54 funds tracked by Wall St. Rank held Sio Gene Therapies Inc. Common Stock as of Q2 2021.

Based on Sio Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.